tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
MoonLake Immunotherapeutics reports Q2 EPS (87c), consensus (76c)
PremiumThe FlyMoonLake Immunotherapeutics reports Q2 EPS (87c), consensus (76c)
24d ago
MoonLake Immunotherapeutics participates in a conference call with Clear Street
Premium
The Fly
MoonLake Immunotherapeutics participates in a conference call with Clear Street
27d ago
MoonLake Immunotherapeutics: Strategic Leadership Transition and Promising Clinical Progress Drive Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Strategic Leadership Transition and Promising Clinical Progress Drive Buy Rating
28d ago
Stat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics
PremiumThe FlyStat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics
3M ago
MoonLake Immunotherapeutics Elects Directors at AGM
Premium
Company Announcements
MoonLake Immunotherapeutics Elects Directors at AGM
3M ago
MoonLake Immunotherapeutics: Strong Acquisition Interest and Promising Product Pipeline Drive Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Strong Acquisition Interest and Promising Product Pipeline Drive Buy Rating
3M ago
Wolfe upgrades MoonLake Immunotherapeutics ahead of sonelokimab data
PremiumThe FlyWolfe upgrades MoonLake Immunotherapeutics ahead of sonelokimab data
3M ago
MoonLake upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
MoonLake upgraded to Outperform from Peer Perform at Wolfe Research
3M ago
MoonLake Immunotherapeutics: Buy Rating Driven by Strategic Developments and Promising Clinical Programs
Premium
Ratings
MoonLake Immunotherapeutics: Buy Rating Driven by Strategic Developments and Promising Clinical Programs
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100